Press Room | News
Nov 26, 2012
KalVista Pharmaceuticals Wins £2.4m Biomedical Catalyst Grant to Further Develop Oral Plasma Kallikrein Inhibitors as a Treatment for Diabetic Macular Edema
read more...
Jan 9, 2012
KalVista Pharmaceuticals and JDRF form research partnership focused on novel approach for treating diabetic eye disease
read more...
Aug 23, 2011
KalVista Pharmaceuticals Launched with £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
read more... |
Kalvista Pharmaceuticals Ltd
Building 227
Tetricus Science Park
Porton Down
SP4 0JQ
United Kingdom
t: +44 1980 611755
e: info@kalvista.com
All content © copyright KalVista Pharmaceuticals. All rights reserved 2011.